COUGHLIN TIMOTHY 4
4 · aTYR PHARMA INC · Filed May 19, 2023
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Coughlin Timothy P
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-17+12,000→ 12,000 totalExercise: $2.52Exp: 2033-05-17→ Common Stock (12,000 underlying) - Gift
Common Stock
2023-05-17+6,000→ 6,000 total(indirect: See Footnote) - Gift
Common Stock
2023-05-17−6,000→ 0 total
Footnotes (2)
- [F1]These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.
- [F2]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.